|
ROMO1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.53359999999214E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.762160E-02 |
| Normal-vs-Stage2 |
1.748010E-02 |
| Normal-vs-Stage3 |
3.174800E-04 |
| Normal-vs-Stage4 |
1.7097000000188E-06 |
| Stage1-vs-Stage2 |
1.411950E-01 |
| Stage1-vs-Stage3 |
1.634170E-01 |
| Stage1-vs-Stage4 |
5.317400E-03 |
| Stage2-vs-Stage3 |
6.089000E-01 |
| Stage2-vs-Stage4 |
5.240800E-01 |
| Stage3-vs-Stage4 |
8.263800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.61120000000371E-05 |
| Normal-vs-AfricanAmerican |
1.021000E-04 |
| Normal-vs-Asian |
3.495200E-01 |
| Caucasian-vs-AfricanAmerican |
7.662800E-03 |
| Caucasian-vs-Asian |
5.008600E-01 |
| AfricanAmerican-vs-Asian |
7.913800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.31490000000001E-05 |
| Normal-vs-Female |
5.620900E-04 |
| Male-vs-Female |
6.670400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.902100E-02 |
| Normal-vs-Age(41-60Yrs) |
3.426300E-04 |
| Normal-vs-Age(61-80Yrs) |
5.186400E-04 |
| Normal-vs-Age(81-100Yrs) |
5.268200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.909400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.309800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.318200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.223800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.795980E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.193000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.458200E-01 |
| Normal-vs-Grade 2 |
5.768200E-02 |
| Normal-vs-Grade 3 |
2.92560000003661E-06 |
| Normal-vs-Grade 4 |
1.59570999999081E-05 |
| Grade 1-vs-Grade 2 |
3.798400E-01 |
| Grade 1-vs-Grade 3 |
2.604400E-02 |
| Grade 1-vs-Grade 4 |
2.962900E-03 |
| Grade 2-vs-Grade 3 |
3.930400E-02 |
| Grade 2-vs-Grade 4 |
5.742100E-03 |
| Grade 3-vs-Grade 4 |
1.273000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.243400E-01 |
| Normal-vs-ccB subtype |
8.40980000000879E-05 |
| ccA subtype-vs-ccB subtype |
1.57455999999501E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.193400E-04 |
| Normal-vs-N1 |
2.561800E-02 |
| N0-vs-N1 |
4.740600E-01 |
|
|
